4 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 2 | Unknown 2 |
Follow Disease Progression: new trials by email Literature Review of Disease Progression trials Research Report on Disease Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients Lopinavir / Ritonavir, Remdesivir (RDV), Tocilizumab - COVID-19, Hospitalized COVID-19 Patients | Phase 1 | Unknown | Lebanese University | 1000 | 2020-03-28 | 2024-02-06 |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors KN044 - Advanced Solid Tumors | Phase 1 | Unknown | Changchun Intellicrown Pharmaceutical Co. LTD | 39 | 2020-01-09 | 2023-09-01 |
| CNDO-109-AANK for AML in First Complete Remission (CR1) CNDO-109-AANK Cells - Acute Myeloid Leukemia | Phase 1 / Phase 2 | Unknown | Coronado Biosciences, Inc. | 12 | 2012-12-01 | 2017-06-29 |
| Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma Sodium selenite (Introselen), Sodium selenite - Malignant Tumor, Treatment Resistant Disorders | Phase 1 / Phase 2 | Unknown | Karolinska University Hospital | 32 | 2007-02-01 | 2013-10-10 |
Pathologic Complete Response (2) · COVID-19 (1) · Inflammation (1) · Leukemia, Myeloid, Acute (1) · Neoplasms (1)
Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Leukemia (1) · Leukemia, Myeloid (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Nidovirales Infections (1)
Lopinavir (1) · Sodium Selenite (1) · lopinavir-ritonavir drug combination (1) · remdesivir (1) · tocilizumab (1)
Changchun Intellicrown Pharmaceutical Co. LTD (1) · Coronado Biosciences, Inc. (1) · Karolinska University Hospital (1) · Lebanese University (1)
China (1) · Lebanon (1) · Sweden (1) · United States (1)
Nehman Makdissy, Professor (1) · Ola Brodin, MD, PhD (1) · Rui Chen (1)